Search research articles
Contact Us
Filters
Showing results (311-320 of 738) with videos related to
Page
of 74
Sort By:
Nutrition and Cancer
|
November 14, 2008
The role of antioxidants and vitamin A in ovarian cancer: results from the Women's Health Initiative
Cynthia A Thomson, Marian L Neuhouser, James M Shikany, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
August 30, 2023
Sequential Targeted Therapy for Advanced, Metastatic, and Recurrent Cervical Cancer: A Cost-Effectiveness Analysis of the Patient Journey
Michael T Richardson, Kristopher Attwood, Gabriella Smith, et al.
Cancer
|
June 29, 2004
Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy: a gynecologic oncology group study
Robert A Burger, Kathleen M Darcy, Philip J DiSaia, et al.
Gynecologic Oncology
|
November 17, 2009
Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study
Shu-Yuan Liao, Kathleen M Darcy, Leslie M Randall, et al.
Gynecologic Oncology
|
July 30, 2020
Bevacizumab plus fosbretabulin in recurrent ovarian cancer: Overall survival and exploratory analyses of a randomized phase II NRG oncology/gynecologic oncology group study
Krishnansu S Tewari, Michael W Sill, Robert L Coleman, et al.
Personality and Mental Health
|
April 22, 2025
Symptom Overlap Between Depression and Borderline Personality Disorder: A Network Analysis
Bess M Kew, Nathan J Monk, Tamlin S Conner, et al.
British Journal of Cancer
|
September 11, 2003
HPV infection and number of lifetime sexual partners are strong predictors for 'natural' regression of CIN 2 and 3
J K Chan, B J Monk, C Brewer, et al.
Cancer Research Communications
|
December 5, 2024
Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical Trials
Hailei Zhang, Anna Rutkowska, Antonio González-Martín, et al.
Gynecologic Oncology
|
July 8, 2005
Conservation of in vitro drug resistance patterns in epithelial ovarian carcinoma
Krishnansu S Tewari, Rita S Mehta, Robert A Burger, et al.
Gynecologic Oncology
|
December 8, 2019
Incorporation of whole pelvic radiation into treatment of stage IVB cervical cancer: A novel treatment strategy
Victoria Perkins, Kathleen Moore, Sara Vesely, et al.
Page
of 74
Search research articles
Search
Showing results (311-320 of 738) with videos related to
Sort By:
Page
of 74
Nutrition and Cancer
|
November 14, 2008
The role of antioxidants and vitamin A in ovarian cancer: results from the Women's Health Initiative
Cynthia A Thomson, Marian L Neuhouser, James M Shikany, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
August 30, 2023
Sequential Targeted Therapy for Advanced, Metastatic, and Recurrent Cervical Cancer: A Cost-Effectiveness Analysis of the Patient Journey
Michael T Richardson, Kristopher Attwood, Gabriella Smith, et al.
Cancer
|
June 29, 2004
Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy: a gynecologic oncology group study
Robert A Burger, Kathleen M Darcy, Philip J DiSaia, et al.
Gynecologic Oncology
|
November 17, 2009
Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study
Shu-Yuan Liao, Kathleen M Darcy, Leslie M Randall, et al.
Gynecologic Oncology
|
July 30, 2020
Bevacizumab plus fosbretabulin in recurrent ovarian cancer: Overall survival and exploratory analyses of a randomized phase II NRG oncology/gynecologic oncology group study
Krishnansu S Tewari, Michael W Sill, Robert L Coleman, et al.
Personality and Mental Health
|
April 22, 2025
Symptom Overlap Between Depression and Borderline Personality Disorder: A Network Analysis
Bess M Kew, Nathan J Monk, Tamlin S Conner, et al.
British Journal of Cancer
|
September 11, 2003
HPV infection and number of lifetime sexual partners are strong predictors for 'natural' regression of CIN 2 and 3
J K Chan, B J Monk, C Brewer, et al.
Cancer Research Communications
|
December 5, 2024
Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical Trials
Hailei Zhang, Anna Rutkowska, Antonio González-Martín, et al.
Gynecologic Oncology
|
July 8, 2005
Conservation of in vitro drug resistance patterns in epithelial ovarian carcinoma
Krishnansu S Tewari, Rita S Mehta, Robert A Burger, et al.
Gynecologic Oncology
|
December 8, 2019
Incorporation of whole pelvic radiation into treatment of stage IVB cervical cancer: A novel treatment strategy
Victoria Perkins, Kathleen Moore, Sara Vesely, et al.
Page
of 74